Last reviewed · How we verify
NCT06908148: SALACIA
SALACIA: SALvesAn vs Conventional Management of dIAbetic Foot Wounds
NA trial testing Electrolysed water in Foot Ulcers, Diabetic in 200 participants. Not yet recruiting.
1 July 2026
Quick facts
| Lead sponsor | NHS Lanarkshire |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 July 2025 |
| Primary completion | 1 July 2026 |
| Estimated completion | 1 September 2026 |
Drugs / interventions tested
- Electrolysed water
- Conventional irrigant
Conditions studied
- Foot Ulcers, Diabetic — all drugs for Foot Ulcers, Diabetic →
- Foot Ulcer Unhealed — all drugs for Foot Ulcer Unhealed →
Sponsor
NHS Lanarkshire
Who can join
Adults 18 to 89, any sex, with Foot Ulcers, Diabetic or Foot Ulcer Unhealed. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Increasing prevalence of diabetes mellitus has led to increasing numbers of chronic non-healing foot ulcers (wounds). Electrolysed water is a novel antiseptic which reduces bacterial load and appears to encourage wound healing. The investigators propose to compare electrolysed water against conventional management.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06908148
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Electrolysed water
Trials testing the same drug.
- NCT02841969 — Management of the Diabetic Foot Using Electrolysed Water · NA · suspended
Other recruiting trials for Foot Ulcers, Diabetic
Currently open trials in the same condition.
- NCT06952998 — Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Ar · Phase 4 · recruiting
Other NHS Lanarkshire trials
Trials by the same sponsor.
- NCT05339191 — Compassionate Imagery for People With An Intellectual Disability · NA · completed
- NCT04438993 — The COVID-19 Disease and CARdiac Events Study · completed
- NCT03659955 — Autologous Blood Treatment for Ocular Surface Disease · NA · completed
- NCT02841969 — Management of the Diabetic Foot Using Electrolysed Water · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06908148 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NHS Lanarkshire
- Last refreshed: 3 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06908148.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing